Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma, Hepatocellular × Dronabinol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Vomiting 3 Pain 3 Nausea 3 Pancreatic Neoplasms 2 Breast Neoplasms 2 Parasomnias 1 Neoplasms 1 Marijuana Abuse 1 Malnutrition 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Hepatocellular 1 Brain Neoplasms 1 Anxiety Disorders 1

Interventions

Sorafenib 121 lenvatinib 99 Bevacizumab 70 Radiosurgery 56 Nivolumab 46 atezolizumab 45 sintilimab 43 Fluorouracil 40 apatinib 39 Oxaliplatin 39 Hepatectomy 39 durvalumab 38 camrelizumab 36 pembrolizumab 31 Radiotherapy 31 Radiofrequency Ablation 31 tislelizumab 28 Leucovorin 28 Magnetic Resonance Spectroscopy 26 Immune Checkpoint Inhibitors 26 Doxorubicin 26 Folfox protocol 23 tremelimumab 22 regorafenib 20 Cyclophosphamide 19 Ethiodized Oil 18 Cisplatin 18 toripalimab 16 spartalizumab 16 donafenib 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06518434 2024-07-24

CanHep

University Medical Center Groningen

Phase 2 Recruiting

Gastrointestinal

Marijuana Abuse, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡